You could be reading the full-text of this article now if you...

If you have access to this article through your institution,
you can view this article in

Pterygium Excision With Conjunctival Autograft: True Survival Rate Statistics

Varssano, David MD*,†; Shalev, Hadas MD; Lazar, Moshe MD*,†; Fischer, Naomi MD*,†

doi: 10.1097/ICO.0b013e31828ce09c
Clinical Science

Purpose: To evaluate the factors influencing long-term survival rate (ie, probability of recurrence-free eye over time) after pterygium excision with conjunctival autograft.

Methods: A retrospective cohort study was performed. All patients who underwent excision of pterygium and conjunctival autograft at a single institution by the same surgeon during the years from 1997 to 2008 were included. Preoperative and postoperative patient data were collected. The patients were invited for follow-up examinations performed by the surgeon, and the recurrence was analyzed using survival rate statistics.

Results: There were 20 recurrences (20/176, 11.4%) during an average follow-up time of 34.4 ± 36.2 months (range, 0.03–129.7 months), with no apparent leveling of the graph. Using survival rate statistics, the estimated mean time to recurrence was 104.5 ± 4.9 months (95% confidence interval, 94.9–114.0 months). Patients younger than 30 years (P = 0.031) and grafts attached with thicker sutures (6/0–8/0, P = 0.005) were more prone to have recurrences. Thin (9/0 or 10/0) nylon and polyglactin sutures had similar results (P = 0.819). Interestingly, pterygia invading less into the cornea probably had more recurrences (P = 0.054). There was an average improvement of logarithm of the minimum angle of resolution from 0.26 (preoperative) to 0.19 (postoperative) (P < 0.014). There were no major complications.

Conclusions: Use of survival rate statistics is indicated because the potential for pterygium recurrence is continuous. Worse prognosis is expected for younger patients, use of thicker sutures and possibly in less invading pterygia.

Author Information

*Department of Ophthalmology, Tel Aviv Medical Center, Tel Aviv, Israel; and

Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Reprints: David Varssano, Department of Ophthalmology, Tel Aviv Medical Center, 6, Weizmann St, Tel Aviv 64236, Israel (e-mail:

Presented at the World Cornea Congress VI April 7–9, 2010, Boston, MA.

The authors have no funding or conflicts of interest to disclose.

Received January 15, 2013

Accepted February 11, 2013

© 2013 by Lippincott Williams & Wilkins.